NCT04427787 2021-09-05
LOLA
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
Clinical Trials
5 trialsNCT02823691 2021-06-07
MetNET-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase EARLY_PHASE1 Unknown
NCT03083210 2019-05-20
Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET
Samsung Medical Center
Phase 4 Unknown
NCT03439709 2018-03-01
MERGE
Samsung Medical Center
Phase 3 Unknown
NCT01731925 2017-01-31
SUNLAND
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Unknown